What Researchers Did
This commentary explored current wound care literature to advocate for an advanced standard of care for diabetic foot ulcers and other chronic wounds.
What They Found
Researchers found that recent advances in wound care therapies and evidence support an advanced standard of care for diabetic foot ulcers and chronic wounds. They noted that if conventional care fails to achieve a 50% wound area reduction within 4 weeks, adjuvant therapies like negative pressure wound therapy, hyperbaric oxygen therapy, growth factors, bioengineered tissue, and extracellular matrix products should be considered.
What This Means for Canadian Patients
Canadian patients with diabetic foot ulcers or chronic wounds that do not show significant improvement with conventional care within four weeks may benefit from a range of advanced therapies. These advanced treatments, including negative pressure wound therapy and bioengineered tissues, could potentially improve healing outcomes and prevent complications.
Canadian Relevance
This commentary does not have a direct Canadian connection.
Study Limitations
As a commentary, this article does not present new research data or a systematic review of the literature, but rather explores a brief selection of current wound care information.